🔎 Trials Near Me

Hjem › Interstitielle lungesygdomme › Texas › Houston

Interstitielle lungesygdomme kliniske forsøg i Houston, TX

12 studier for Interstitielle lungesygdomme søger deltagere på steder i og omkring Houston (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

RekruttererFase 3
  • Baylor College of Medicine, Houston
Alder 40 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07201922

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

RekruttererFase 3
  • GSK Investigational Site, Houston
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT06572384

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

RekruttererFase 2
  • Baylor College of Medicine, Houston
Alder 40 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT06968845

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

Rekrutterer
  • Baylor College of Medicine, Houston
  • Houston Methodist Hospital, Houston
Alder 18 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT06911632

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

RekruttererFase 2
  • Clinical Research Site, Houston
Alder 18 til 85 · Alle køn · Opdateret 2. sep. 2026 · NCT07333183

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

RekruttererObservationsstudie
  • Houston Methodist, Houston
  • University of Texas Health Science Center at Houston, Houston
Alder 18 og opefter · Alle køn · Opdateret 26. aug. 2026 · NCT06388421

Platform Clinical Study for Conquering Scleroderma

RekruttererFase 2
  • University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics, Houston
Alder 18 og opefter · Alle køn · Opdateret 18. aug. 2026 · NCT06195072

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

RekruttererObservationsstudie
  • Baylor College of Medicine, Houston
  • Houston Methodist Lung Center, Houston
  • The University of Texas Health Science Center At Houston, Houston
Alder 21 og opefter · Alle køn · Opdateret 12. aug. 2026 · NCT01915511

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

RekruttererFase 2
  • Houston Methodist Hospital, Houston
Alder 18 til 80 · Alle køn · Opdateret 10. aug. 2026 · NCT07175038

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

RekruttererFase 3
  • Houston Methodist Outpatient Center, Houston
  • The University of Texas Health Science Center at Houston, McGovern Medical School, Houston
Alder 18 og opefter · Alle køn · Opdateret 13. jul. 2026 · NCT05943535

TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients

RekruttererObservationsstudie
  • Baylor College of Medicine/Texas Children'S Hospital, Houston
Op til 24 år · Alle køn · Opdateret 22. jun. 2026 · NCT04098445

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

RekruttererFase 2
  • aTyr Investigative Site, Houston
Alder 18 og opefter · Alle køn · Opdateret 7. maj 2025 · NCT05892614

Interstitielle lungesygdomme forsøg i andre byer

Andre studier i Houston

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.